Can’t Describe Your Feelings? Scientists Found the Possible Genetic Cause of Alexithymia

Struggling to describe or recognize emotions is a challenge faced by some individuals due to a personality trait called alexithymia. This condition, which means “no words for emotions,” has drawn the attention of psychologists and scientists because of its significant impact on mental and physical health. A team of researchers, including Professor Yazmín Hernández-Díaz and Dr. Alma Genis-Mendoza, reviewed scientific studies to uncover whether genes play a role in this condition. Their work, published in the journal Genes, sheds light on the biological factors behind alexithymia.

Professor Hernández-Díaz and  Dr. Genis-Mendoza’s team analyzed research involving large groups of people. They focused on genetic studies exploring serotonin pathways, the system that regulates mood and emotions, brain chemicals, and other biological processes. According to Professor Hernández-Díaz, “The majority of alexithymia genes and polymorphisms in this study belong to the serotoninergic pathway and neurotransmitter metabolism genes, suggesting a role of serotoninergic neurotransmission in alexithymia.”

Researchers identified several key genes linked to emotional awareness and regulation. One notable gene, responsible for transporting serotonin, a brain chemical that stabilizes mood and happiness, showed strong connections to alexithymia. People with certain variations in this gene had more difficulty identifying emotions. The team also found gender differences in alexithymia, with men generally showing higher tendencies than women. This highlights how both biological and social factors can influence the condition.

Another major area explored involved genes related to brain chemicals that manage emotions. Variants in the dopamine receptor gene, which impacts feelings of reward and pleasure, oxytocin receptor gene, which influences bonding and trust, and a gene known for breaking down stress hormones were found to affect emotional regulation. For example, people with certain forms of the gene related to dopamine processing had more challenges managing their emotions. Similarly, changes in the oxytocin receptor gene were linked to reduced empathy and emotional connection.

Dr. Genis-Mendoza shared, “Our findings highlight how serotonin and other brain chemical systems play a major role in shaping how people experience and express emotions. These insights may open doors to targeted therapies to help those affected by alexithymia.”

Challenges remain despite the progress made. Large-scale genetic studies, which examine the entire genome for relevant variations, for alexithymia are lacking, and inconsistencies exist when comparing findings across different populations. The research team emphasizes the need for larger, diverse studies that consider environmental influences alongside genetics to provide a clearer picture.

The importance of this research cannot be understated. Alexithymia is linked to various mental health challenges, such as depression and anxiety, and even physical health conditions. Understanding the genetic factors behind this condition could lead to personalized treatments. Future studies may explore how environmental factors, such as stress or upbringing, interact with genetic predispositions to further refine therapies.

Comprehending the biological framework of alexithymia not only deepens our understanding of this condition but also opens opportunities for addressing broader mental health concerns. By connecting psychology and biology, this research brings hope to those facing challenges with emotional awareness and regulation.